Suheir Assady

1.3k total citations · 1 hit paper
15 papers, 900 citations indexed

About

Suheir Assady is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suheir Assady has authored 15 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suheir Assady's work include Renal Diseases and Glomerulopathies (4 papers), Pancreatic function and diabetes (3 papers) and Pluripotent Stem Cells Research (2 papers). Suheir Assady is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Pancreatic function and diabetes (3 papers) and Pluripotent Stem Cells Research (2 papers). Suheir Assady collaborates with scholars based in Israel, United States and Germany. Suheir Assady's co-authors include Karl Skorecki, Joseph Itskovitz‐Eldor, Gila Maor, Michal Amit, Maty Tzukerman, Zaid Abassi, Nicola Wanner, Tobias B. Huber, Zaher Armaly and Farid Nakhoul and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes.

In The Last Decade

Suheir Assady

14 papers receiving 871 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin Production by Human Embryonic Stem Cells

2001 658 citations Suheir Assady, Gila Maor et al. Diabetes profile →

Peers

Suheir Assady

MB

SURGE

GENET

EDM

NEPHR

Sara Tezza United States

Roland Gander Austria

Anna Milanesi United States

Nicola Marangon Switzerland

Qiwei Sun United States

H Jahr Germany

Shin Ishikane Japan

Zhaoshun Jiang China

Nabil A. Rashdan United States

Bettina Krueger Germany

Sara Tezza United States

Suheir Assady

147 ×0.3

MB

257 ×0.5

SURGE

224 ×0.9

GENET

135 ×0.7

EDM

28 ×0.3

NEPHR

Citations per year, relative to Suheir Assady Suheir Assady (= 1×) peers Sara Tezza

Countries citing papers authored by Suheir Assady

Since Specialization

Citations

This map shows the geographic impact of Suheir Assady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suheir Assady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suheir Assady more than expected).

Fields of papers citing papers by Suheir Assady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suheir Assady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suheir Assady. The network helps show where Suheir Assady may publish in the future.

Co-authorship network of co-authors of Suheir Assady

This figure shows the co-authorship network connecting the top 25 collaborators of Suheir Assady. A scholar is included among the top collaborators of Suheir Assady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suheir Assady. Suheir Assady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Gamliel-Lazarovich, Aviva, Yaniv Zohar, Neta Ilan, et al.. (2022). Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury. International Journal of Molecular Sciences. 23(20). 12691–12691. 2 indexed citations

2.

Milo, Gai, et al.. (2021). Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury. Journal of Oncology Pharmacy Practice. 28(2). 508–515. 7 indexed citations

3.

Dolnikov, Katya, et al.. (2020). Scleroderma Renal Crisis as an Early Presentation of Systemic Sclerosis.. PubMed. 11(22). 722–723. 1 indexed citations

4.

Assady, Suheir, Thomas Benzing, Matthias Kretzler, & Karl Skorecki. (2019). Glomerular podocytes in kidney health and disease. The Lancet. 393(10174). 856–858. 20 indexed citations

5.

Assady, Suheir, Nicola Wanner, Karl Skorecki, & Tobias B. Huber. (2017). New Insights into Podocyte Biology in Glomerular Health and Disease. Journal of the American Society of Nephrology. 28(6). 1707–1715. 82 indexed citations

6.

Milo, Gai, et al.. (2017). [HEMODIALYSIS: PRESENT INNOVATIONS FOR PATIENTS' FUTURE].. PubMed. 156(9). 595–599. 2 indexed citations

7.

Assady, Suheir, Joel Alter, Yaniv Zohar, et al.. (2015). Nephroprotective Effect of Heparanase in Experimental Nephrotic Syndrome. PLoS ONE. 10(3). e0119610–e0119610. 10 indexed citations

8.

Armaly, Zaher, Suheir Assady, & Zaid Abassi. (2013). Corin. Current Opinion in Nephrology & Hypertension. 22(6). 713–722. 39 indexed citations

9.

Assady, Suheir, Radu Ionescu, Raneen Jeries, et al.. (2013). Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End-Stage Renal Disease: A Pilot Study. Nanomedicine. 9(7). 1035–1045. 28 indexed citations

10.

Bar‐Sela, Gil, et al.. (2012). Evaluation of carboplatin dosing in non-small cell lung carcinoma patients using Calvert formula and Cockroft and Gault equation for glomerular filtration rate estimation. Oncology Letters. 4(5). 1072–1076.

11.

Yigla, Mordechai, et al.. (2010). Obstructive uropathy caused by retroperitoneal fibrosis presents as a late manifestation of sarcoidosis. Renal Failure. 32(9). 1118–1120. 5 indexed citations

12.

Assady, Suheir. (2009). Challenges and prospects for stem cell-based therapy in diabetes mellitus.. PubMed. 11(4). 212–5. 1 indexed citations

13.

Nakhoul, Farid, et al.. (2005). Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. American Journal of Physiology-Renal Physiology. 289(4). F880–F890. 35 indexed citations

14.

Assady, Suheir, Gila Maor, Michal Amit, et al.. (2001). Insulin Production by Human Embryonic Stem Cells. Diabetes. 50(8). 1691–1697. 658 indexed citations breakdown →

15.

Green, Jacob, Suheir Assady, Farid Nakhoul, et al.. (2000). Differential Effects of Sera from Normotensive and Hypertensive Pregnant Women on Ca2+ Metabolism in Normal Vasular Smooth Muscle Cells. Journal of the American Society of Nephrology. 11(7). 1188–1198. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact